(Q39158036)

9 September 2017

Discovery of a potent inhibitor of anaplastic lymphoma kinase with in vivo antitumor activity (English)

1 reference

9 September 2017

Gregory R Ott

1

1 reference

9 September 2017

Rabindranath Tripathy

2

1 reference

9 September 2017

Mangeng Cheng

3

1 reference

9 September 2017

Robert McHugh

4

1 reference

9 September 2017

Andrew V Anzalone

5

1 reference

9 September 2017

Ted L Underiner

6

1 reference

9 September 2017

Matthew A Curry

7

1 reference

9 September 2017

Matthew R Quail

8

1 reference

9 September 2017

Lihui Lu

9

1 reference

9 September 2017

Weihua Wan

10

1 reference

9 September 2017

Thelma S Angeles

11

1 reference

9 September 2017

Mark S Albom

12

1 reference

9 September 2017

Lisa D Aimone

13

1 reference

9 September 2017

Mark A Ator

14

1 reference

9 September 2017

Bruce A Ruggeri

15

1 reference

9 September 2017

Bruce D Dorsey

16

1 reference

9 September 2017

language of work or name

1 reference

1 September 2010

1 reference

ACS Medicinal Chemistry Letters

9 September 2017

1 reference

9 September 2017

1

1 reference

9 September 2017

9

1 reference

9 September 2017

493-498

1 reference

Crystal structures of anaplastic lymphoma kinase in complex with ATP competitive inhibitors

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007912

Crystal structure of the ALK (anaplastic lymphoma kinase) catalytic domain

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007912

The biology and treatment of EML4-ALK non-small cell lung cancer

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007912

Discovery of a 2,4-disubstituted pyrrolo[1,2-f][1,2,4]triazine inhibitor (BMS-754807) of insulin-like growth factor receptor (IGF-1R) kinase in clinical development

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007912

Inhibition of ALK signaling for cancer therapy

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007912

Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007912

A quantitative analysis of kinase inhibitor selectivity

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007912

The anaplastic lymphoma kinase in the pathogenesis of cancer

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007912

Cytoreductive antitumor activity of PF-2341066, a novel inhibitor of anaplastic lymphoma kinase and c-Met, in experimental models of anaplastic large-cell lymphoma

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007912

Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007912

Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK.

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007912

Design and synthesis of 5-aryl-pyridone-carboxamides as inhibitors of anaplastic lymphoma kinase

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007912

Novel 2-phenylquinolin-7-yl-derived imidazo[1,5-a]pyrazines as potent insulin-like growth factor-I receptor (IGF-IR) inhibitors

10 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007912

Anaplastic lymphoma kinase activity is essential for the proliferation and survival of anaplastic large-cell lymphoma cells

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007912

Synthesis and structure-activity relationships of 1,2,3,4-tetrahydropyrido[2,3-b]pyrazines as potent and selective inhibitors of the anaplastic lymphoma kinase

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007912

GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers

21 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4007912

Physiological parameters in laboratory animals and humans

21 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24900237

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Dynamic and static conformational analysis of acylated tetrahydrobenzazepines

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24900237

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Oligomers of cis-beta-norbornene amino acid: formation of beta-strand mimetics.

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24900237

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1021/ML100158S

1 reference

9 September 2017

1 reference

9 September 2017

1 reference